| Financial Year |
March 31 2023 |
| Monetary Funds |
7,397,731,657.22 |
| Held-for-trading Financial Assets |
73,622,915.39 |
| Notes Receivable |
483,790,656.35 |
| Accounts Receivable |
1,407,593,943.71 |
| Advances to Suppliers |
213,651,783.31 |
| Other Receivables |
38,994,738.77 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,790,537,782.43 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
36,306,849.44 |
| Total Current Assets |
12,933,491,386.75 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
2,790,368,387.15 |
| Under-construction Projects |
527,524,810.43 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
437,312,164.65 |
| R&D expenses |
-- |
| Goodwill |
665,824.27 |
| Long-Term Deferred and Prepaid Expenses |
16,729,701.11 |
| Deferred Income Tax Assets |
57,753,949.42 |
| Other Non-Current Assets |
179,957,643.36 |
| Sub-Total of Non-Current Assets |
4,016,338,971.12 |
| Total Assets |
16,949,830,357.87 |
| Short-Term Loans |
252,612,576.98 |
| Trading Financial liabilities |
-- |
| Notes Payable |
527,663,308.43 |
| Accounts Payable |
894,394,789.34 |
| Accounts Received In Advance |
11,922,994.23 |
| Employee Compensation Payable |
136,272,967.73 |
| Taxes Payable |
151,730,851.55 |
| Interest Payable |
-- |
| Dividend Payable |
658,981,575.77 |
| Other payables |
672,927,375.33 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
52,529,885.78 |
| Other Current Liabilities |
157,140,798.82 |
| Sub-Total of Current Liabilities |
3,233,281,073.65 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
188,284,239.59 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
386,190,285.53 |
| Total Liabilities |
3,619,471,359.18 |
| Paid-In Capital(Or Share Stock) |
1,340,820,992.00 |
| Capital Surplus |
3,364,863,894.97 |
| Surplus Reserve |
670,410,496.00 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
7,838,031,905.93 |
| Minority Stockholder's Interest |
49,003,899.70 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
13,281,355,098.99 |
| Owner's Equity（Stockholder's Equity） |
13,330,358,998.69 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
16,949,830,357.87 |
